Correlation Between Abbott Laboratories and Armm
Can any of the company-specific risk be diversified away by investing in both Abbott Laboratories and Armm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abbott Laboratories and Armm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abbott Laboratories and Armm Inc, you can compare the effects of market volatilities on Abbott Laboratories and Armm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abbott Laboratories with a short position of Armm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abbott Laboratories and Armm.
Diversification Opportunities for Abbott Laboratories and Armm
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Abbott and Armm is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Abbott Laboratories and Armm Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Armm Inc and Abbott Laboratories is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abbott Laboratories are associated (or correlated) with Armm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Armm Inc has no effect on the direction of Abbott Laboratories i.e., Abbott Laboratories and Armm go up and down completely randomly.
Pair Corralation between Abbott Laboratories and Armm
If you would invest 11,439 in Abbott Laboratories on December 27, 2024 and sell it today you would earn a total of 1,222 from holding Abbott Laboratories or generate 10.68% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 95.24% |
Values | Daily Returns |
Abbott Laboratories vs. Armm Inc
Performance |
Timeline |
Abbott Laboratories |
Armm Inc |
Abbott Laboratories and Armm Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Abbott Laboratories and Armm
The main advantage of trading using opposite Abbott Laboratories and Armm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abbott Laboratories position performs unexpectedly, Armm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Armm will offset losses from the drop in Armm's long position.Abbott Laboratories vs. AbbVie Inc | Abbott Laboratories vs. Eli Lilly and | Abbott Laboratories vs. Bristol Myers Squibb | Abbott Laboratories vs. Johnson Johnson |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Fundamental Analysis View fundamental data based on most recent published financial statements |